Evaluation of the Importance of Capsule Transparency in Dry Powder Inhalation Devices

Area of Science:

• Respiratory Medicine
• Pharmaceutical Technology
• Clinical Trials

Background:

• Accurate assessment of inhaled drug delivery is crucial for managing chronic airway diseases.
• Residual capsule weight after inhalation is a potential surrogate for the inhaled delivered dose.
• Current dry powder inhaler (DPI) devices often use opaque capsules, limiting visual feedback.

Purpose of the Study:

• To evaluate if transparent capsules in DPIs improve the accuracy of residual capsule weight as a surrogate for inhaled dose.
• To compare the weight decrease of transparent versus opaque capsules after patient inhalation.
• To assess the impact of capsule transparency on verifying inhalation technique.

Main Methods:

• An observational, cross-sectional study design was employed.
• Ninety-one patients with non-reversible chronic airway disease using single-dose DPIs were included.
• Capsule weight was measured pre- and post-inhalation using a precision microbalance.

Main Results:

• A significantly greater weight decrease was observed with transparent capsules (30.1%) compared to opaque capsules (8.6%) (P < 0.001).
• A higher proportion of patients (69.2%) used transparent capsules during the study.
• The findings indicate a substantial difference in residual capsule weight based on capsule transparency.

Conclusions:

• Transparent capsules offer a more sensitive surrogate for inhaled delivered dose by showing a greater weight reduction post-inhalation.
• The study highlights the importance of visual feedback mechanisms in DPIs to ensure correct patient inhalation technique.
• Implementing transparent capsules could enhance patient adherence and treatment efficacy in chronic airway disease management.